Immunometabolic Dysfunction of Natural Killer Cells Mediated by the Hypoxia-CD73 Axis in Solid Tumors

Area of Science:

• Immunology
• Cancer Biology
• Metabolic Signaling

Background:

• Natural killer (NK) cell infiltration in solid tumors is often limited, primarily by the less cytotoxic CD56^bright subset.
• CD73, upregulated in hypoxia, correlates with tumor invasiveness, metastasis, and reduced patient survival across various cancers.
• Hypoxia promotes cancer cell glycolysis, reprogramming NK cell metabolism and contributing to tumor-promoting environments.

Purpose of the Study:

• To review the role of hypoxic signaling in CD73-mediated activity within the tumor microenvironment.
• To explore the immunometabolic reprogramming of NK cells under hypoxia and CD73 expression.
• To discuss the therapeutic potential of targeting hypoxia/CD73 signaling to enhance NK cell anti-tumor functions.

Main Methods:

• Literature review and synthesis of existing evidence on hypoxia, CD73, adenosine signaling, and NK cell immunometabolism.
• Analysis of the interplay between hypoxic conditions, CD73 activity, and NK cell functional impairment.
• Discussion of therapeutic strategies targeting these interconnected pathways.

Main Results:

• Hypoxia-driven CD73 activity generates adenosine, a potent immunosuppressive metabolite that impairs NK cell metabolism and function.
• Adenosine signaling alters NK cell metabolic programs, fostering tumor immune evasion and dysfunction.
• The combined effects of hypoxia and CD73 create a tumor microenvironment that suppresses effective NK cell responses.

Conclusions:

• The hypoxia-CD73-adenosine axis represents a critical mechanism of NK cell suppression in solid tumors.
• Understanding this pathway is crucial for developing novel immunotherapies.
• Targeting the hypoxia-CD73-adenosine axis holds promise for reinvigorating NK cell activity against cancer.